[{"address1": "18000 Studebaker Road", "address2": "Suite 800", "city": "Cerritos", "state": "CA", "zip": "90703", "country": "United States", "phone": "562 735 3226", "website": "https://theoncologyinstitute.com", "industry": "Medical Care Facilities", "industryKey": "medical-care-facilities", "industryDisp": "Medical Care Facilities", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.", "fullTimeEmployees": 825, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard Alan Barasch", "age": 70, "title": "Chairman of the Board", "yearBorn": 1954, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel  Virnich FACHE, M.B.A., M.D.", "age": 45, "title": "CEO & Executive Director", "yearBorn": 1979, "fiscalYear": 2024, "totalPay": 704251, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeremy N. Castle M.B.A.", "age": 40, "title": "Chief Operations Officer", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 475950, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 573764, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Carter", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Austin  Lee", "title": "VP of Accounting & Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Hueppelsheuser Esq.", "title": "General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jordan  McInerney", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Cella", "title": "Senior Vice President of Finance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.99, "open": 2.97, "dayLow": 2.9, "dayHigh": 3.26, "regularMarketPreviousClose": 2.99, "regularMarketOpen": 2.97, "regularMarketDayLow": 2.9, "regularMarketDayHigh": 3.26, "payoutRatio": 0.0, "beta": 0.065, "forwardPE": -18.875, "volume": 2094057, "regularMarketVolume": 2094057, "averageVolume": 1237814, "averageVolume10days": 2410730, "averageDailyVolume10Day": 2410730, "bid": 2.99, "ask": 3.05, "bidSize": 3, "askSize": 5, "marketCap": 269486976, "fiftyTwoWeekLow": 0.125, "fiftyTwoWeekHigh": 3.5, "priceToSalesTrailing12Months": 0.66845006, "fiftyDayAverage": 2.06708, "twoHundredDayAverage": 0.83777, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 332145024, "profitMargins": -0.15964, "floatShares": 59721714, "sharesOutstanding": 89234096, "sharesShort": 1480130, "sharesShortPriorMonth": 1292884, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.016900001, "heldPercentInsiders": 0.14325, "heldPercentInstitutions": 0.35384998, "shortRatio": 1.01, "shortPercentOfFloat": 0.0209, "impliedSharesOutstanding": 89234096, "bookValue": 0.057, "priceToBook": 52.982456, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -52808000, "trailingEps": -0.7, "forwardEps": -0.16, "enterpriseToRevenue": 0.824, "enterpriseToEbitda": -7.304, "52WeekChange": 5.3048015, "SandP52WeekChange": 0.09362543, "quoteType": "EQUITY", "currentPrice": 3.02, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 39739000, "totalCashPerShare": 0.445, "ebitda": -45475000, "totalDebt": 102397000, "quickRatio": 1.502, "currentRatio": 1.794, "totalRevenue": 403152000, "debtToEquity": 2020.063, "revenuePerShare": 5.321, "returnOnAssets": -0.17657, "returnOnEquity": -2.7761898, "grossProfits": 59277000, "freeCashflow": 5575250, "operatingCashflow": -15643000, "revenueGrowth": 0.103, "grossMargins": 0.14703, "ebitdaMargins": -0.112799995, "operatingMargins": -0.09493, "financialCurrency": "USD", "symbol": "TOI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591277400000, "cryptoTradeable": false, "exchange": "NCM", "messageBoardId": "finmb_661363343", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1748044380, "regularMarketTime": 1748030401, "shortName": "The Oncology Institute, Inc.", "longName": "The Oncology Institute, Inc.", "postMarketChangePercent": -1.98675, "postMarketPrice": 2.96, "postMarketChange": -0.0599999, "regularMarketChange": 0.029999971, "regularMarketDayRange": "2.9 - 3.26", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1237814, "fiftyTwoWeekLowChange": 2.895, "fiftyTwoWeekLowChangePercent": 23.16, "fiftyTwoWeekRange": "0.125 - 3.5", "fiftyTwoWeekHighChange": -0.48000002, "fiftyTwoWeekHighChangePercent": -0.13714287, "fiftyTwoWeekChangePercent": 530.48016, "earningsTimestamp": 1742932800, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "earningsCallTimestampStart": 1742936400, "earningsCallTimestampEnd": 1742936400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.7, "epsForward": -0.16, "fiftyDayAverageChange": 0.95291996, "fiftyDayAverageChangePercent": 0.4609981, "twoHundredDayAverageChange": 2.18223, "twoHundredDayAverageChangePercent": 2.604808, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "marketState": "CLOSED", "regularMarketChangePercent": 1.0033435, "regularMarketPrice": 3.02, "displayName": "The Oncology Institute", "trailingPegRatio": null, "__fetch_time": "2025-05-24"}]